These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 11008656)

  • 21. Immune response to M. leprae of healthy leprosy contacts.
    Godal T; Lofgren M; Negassi K
    Int J Lepr Other Mycobact Dis; 1972; 40(3):243-50. PubMed ID: 4574270
    [No Abstract]   [Full Text] [Related]  

  • 22. "Tuberculoid contamination" in histoid hanseniasis.
    Corcos MG; Corcos CD
    Int J Lepr Other Mycobact Dis; 1994 Jun; 62(2):301-5. PubMed ID: 8046273
    [No Abstract]   [Full Text] [Related]  

  • 23. PGL-I antibody in HIV infected patients.
    González-Abreu E; Rodriquez ME; Pérez J; Rodríguez J; González A
    Lepr Rev; 1993 Sep; 64(3):275-6. PubMed ID: 8231609
    [No Abstract]   [Full Text] [Related]  

  • 24. HIV seroprevalence in leprosy patients.
    Hussain T; Kulshreshtha K; Ghei SK; Natarajan M; Katoch K; Sengupta U
    Int J Lepr Other Mycobact Dis; 2000 Mar; 68(1):67-9. PubMed ID: 10834073
    [No Abstract]   [Full Text] [Related]  

  • 25. Learning from leprosy: insight into the human innate immune response.
    Montoya D; Modlin RL
    Adv Immunol; 2010; 105():1-24. PubMed ID: 20510728
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HLA and leprosy in the pre and postgenomic eras.
    Geluk A; Ottenhoff TH
    Hum Immunol; 2006 Jun; 67(6):439-45. PubMed ID: 16728267
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Leprosy as an immunological model].
    Godal T; Myrvang B; Samuel DR
    Tidsskr Nor Laegeforen; 1973 Feb; 93(4):217-22. PubMed ID: 4570661
    [No Abstract]   [Full Text] [Related]  

  • 28. Antileprosy protective vaccination of sooty mangabey monkeys with BCG or BCG plus heat-killed Mycobacterium leprae: immunologic observations.
    Gormus BJ; Baskin GB; Xu K; Ratterree MS; Martin LN; Mack PA; Bohm RP; Meyers WM; Walsh GP
    Int J Lepr Other Mycobact Dis; 2000 Dec; 68(4):434-43. PubMed ID: 11332286
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical and histological features of leprosy and human immunodeficiency virus co-infection in Brazil.
    Deps P; Lucas S; Porro AM; Maeda SM; Tomimori J; Guidella C; Reuter T; Oliveira NS; Madureira BP; Souza VA; Loureiro RM; Alves BL; Bellone A; Lockwood DN
    Clin Exp Dermatol; 2013 Jul; 38(5):470-7. PubMed ID: 23678890
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Unresponsiveness to Mycobacterium leprae in lepromatous leprosy in vitro: reversible or not?
    Ottenhoff TH; Elferink DG; de Vries RR
    Int J Lepr Other Mycobact Dis; 1984 Sep; 52(3):419-24. PubMed ID: 6384079
    [No Abstract]   [Full Text] [Related]  

  • 31. Mechanism of "reactions" in borderline tuberculoid (BT) leprosy. A preliminary report.
    Godal T; Myrvang B; Samuel DR; Ross WF; Lofgren M
    Acta Pathol Microbiol Scand Suppl; 1973; 236(0):45-53. PubMed ID: 4602874
    [No Abstract]   [Full Text] [Related]  

  • 32. Borderline tuberculoid leprosy with upgrading Type 1 reaction in a HIV seropositive patient, after antiretroviral therapy: an immune reconstitution inflammatory syndrome.
    Kar HK; Sharma P; Bhardwaj M
    Lepr Rev; 2009 Mar; 80(1):85-8. PubMed ID: 19472856
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Leprosy in HIV infection: a study of three cases.
    Rath N; Kar HK
    Indian J Lepr; 2003; 75(4):355-9. PubMed ID: 15242274
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Current thoughts on the immunology of leprosy].
    Sagaró Delgado B; Díaz de la Rocha Quevedo A; Díaz García MA; Martínez Granja R; Rodríguez García MA; Collazo Caballero S
    Rev Cubana Med Trop; 1988; 40(1):80-90. PubMed ID: 3045919
    [No Abstract]   [Full Text] [Related]  

  • 35. Experimental Mycobacterium leprae infection in BALB/c mice: effect of BCG administration on TNF-alpha production and granuloma development.
    Aarestrup FM; Sampaio EP; de Moraes MO; Albuquerque EC; Castro AP; Sarno EN
    Int J Lepr Other Mycobact Dis; 2000 Jun; 68(2):156-66. PubMed ID: 11036496
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lepra reactions.
    Godal T
    Ethiop Med J; 1973 Apr; 11(2):194-5. PubMed ID: 4596877
    [No Abstract]   [Full Text] [Related]  

  • 37. Rational combination of peptides derived from different Mycobacterium leprae proteins improves sensitivity for immunodiagnosis of M. leprae infection.
    Geluk A; van der Ploeg J; Teles RO; Franken KL; Prins C; Drijfhout JW; Sarno EN; Sampaio EP; Ottenhoff TH
    Clin Vaccine Immunol; 2008 Mar; 15(3):522-33. PubMed ID: 18199740
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thalidomide does not modify the ability of cells in leprosy patients to incorporate [3H]-thymidine when incubated with M. leprae antigens.
    Tadesse A; Taye E; Sandoval F; Shannon EJ
    Lepr Rev; 2003 Sep; 74(3):206-14. PubMed ID: 14577465
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Extended studies on subclinical infection in leprosy.
    Bharadwaj VP; Ramu G; Desikan KV; Katoch K
    Indian J Lepr; 1984; 56(4):807-12. PubMed ID: 6398341
    [No Abstract]   [Full Text] [Related]  

  • 40. Studies on cellular immunity in leprosy. I. Lysosomal enzymes.
    Avila JL; Convit J
    Int J Lepr Other Mycobact Dis; 1970; 38(4):359-64. PubMed ID: 4929372
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.